TR200504890T1 - Benipidin hidroklorür içeren farmasötik bileşim - Google Patents
Benipidin hidroklorür içeren farmasötik bileşimInfo
- Publication number
- TR200504890T1 TR200504890T1 TR2005/04890T TR200504890T TR200504890T1 TR 200504890 T1 TR200504890 T1 TR 200504890T1 TR 2005/04890 T TR2005/04890 T TR 2005/04890T TR 200504890 T TR200504890 T TR 200504890T TR 200504890 T1 TR200504890 T1 TR 200504890T1
- Authority
- TR
- Turkey
- Prior art keywords
- hydrochloride
- pharmaceutical composition
- benipidine
- benidipine
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut buluş, benidipin hidroklorür içeren bir farmasötik bileşim ve benzerlerini sağlamaktadır, özelliği, ana bileşen olan benidipin hidroklorürün emilimini hızlandıran hızlı çözünme özelliğine sahip olan benidipin hidroklorür içeren bir farmasötikbileşim ve benzerlerini sağlamak için, bileşimin hacim-ortalama parçacık boyutu 1.0 ila 50.0 um olan kristalimsi benidipin hidroklorür içermesi veya kristalimsi benidipin hidroklorür ve suda çözünebilen veya su çekici yardımcı madde içeren, hacim-ortalama parçacık boyutu 1.0 ila 50.0 um olan toz parçacıkları içermesidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003171503 | 2003-06-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200504890T1 true TR200504890T1 (tr) | 2006-08-21 |
Family
ID=33549456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2005/04890T TR200504890T1 (tr) | 2003-06-17 | 2005-12-08 | Benipidin hidroklorür içeren farmasötik bileşim |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP3786287B2 (tr) |
KR (1) | KR101060885B1 (tr) |
CN (2) | CN1794993A (tr) |
TR (1) | TR200504890T1 (tr) |
WO (1) | WO2004110448A1 (tr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006133045A1 (en) * | 2005-06-03 | 2006-12-14 | Elan Pharma International, Limited | Nanoparticulate benidipine compositions |
JPWO2008117707A1 (ja) * | 2007-03-23 | 2010-07-15 | 第一三共株式会社 | オルメサルタンメドキソミルの粉砕結晶 |
MY149356A (en) | 2007-03-29 | 2013-08-30 | Daiichi Sankyo Co Ltd | Pharmaceutical composition |
CA2793525C (en) | 2010-03-19 | 2014-05-06 | Daiichi Sankyo Company, Limited | Method for improving dissolution of anticoagulant agent |
EP2700632A4 (en) | 2011-04-18 | 2014-09-03 | Hefei Beini Medical Technology Company Ltd | METHOD FOR CLEANING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AND PRODUCING NANOPARTICLES THEREFOR |
WO2012142816A1 (en) * | 2011-04-18 | 2012-10-26 | Hefei Beini Medical Technology Company, Ltd | Benidipine hydrochloride nanoparticles and preparation method thereof |
BR112014002397B1 (pt) | 2011-08-10 | 2021-08-03 | Daiichi Sankyo Company, Limited | Formulação sólida na forma de tablete ou cápsula contendo derivado de diamida |
CN102362865B (zh) * | 2011-10-28 | 2013-06-26 | 山东司邦得制药有限公司 | 一种含有盐酸贝尼地平和缬沙坦的复方制剂及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55129221A (en) * | 1979-03-29 | 1980-10-06 | Kaken Pharmaceut Co Ltd | Preparation of oral preparation containing hardly soluble medicine |
JPS59137461A (ja) * | 1983-01-27 | 1984-08-07 | Kyowa Hakko Kogyo Co Ltd | 1,4−ジヒドロピリジン誘導体 |
JPH06128147A (ja) * | 1992-10-20 | 1994-05-10 | Masayasu Sugihara | 水難溶性薬品の溶解性改善方法およびそれにより得られた薬品組成物 |
JPH07126154A (ja) * | 1993-10-29 | 1995-05-16 | Terumo Corp | 難水溶性医薬品含有医薬製剤 |
JP2003104888A (ja) * | 2001-09-28 | 2003-04-09 | Taiyo Yakuhin Kogyo Kk | ジヒドロピリジン誘導体の錠剤 |
-
2004
- 2004-06-17 CN CNA2004800141288A patent/CN1794993A/zh active Pending
- 2004-06-17 CN CN2011100220991A patent/CN102166212A/zh active Pending
- 2004-06-17 KR KR1020057024145A patent/KR101060885B1/ko active IP Right Grant
- 2004-06-17 WO PCT/JP2004/008821 patent/WO2004110448A1/ja active Application Filing
- 2004-06-17 JP JP2005505044A patent/JP3786287B2/ja not_active Expired - Lifetime
-
2005
- 2005-12-08 TR TR2005/04890T patent/TR200504890T1/tr unknown
Also Published As
Publication number | Publication date |
---|---|
CN102166212A (zh) | 2011-08-31 |
JP3786287B2 (ja) | 2006-06-14 |
KR101060885B1 (ko) | 2011-08-31 |
WO2004110448A1 (ja) | 2004-12-23 |
CN1794993A (zh) | 2006-06-28 |
JPWO2004110448A1 (ja) | 2006-07-20 |
KR20060020681A (ko) | 2006-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200504890T1 (tr) | Benipidin hidroklorür içeren farmasötik bileşim | |
AU2003274681A8 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
CY2016024I1 (el) | ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ | |
RS53666B1 (en) | CRYSTALS OF SODIUM LAKVINIMOD AND THE PROCESS FOR OBTAINING THEM | |
IL220888A0 (en) | 3,10 and 12 a substituted tetracyline compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
HUP0400384A3 (en) | Benzamidine derivative and pharmaceutical compositions containing them and their use | |
DE69934135D1 (de) | Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen | |
ATE533476T1 (de) | Komprimierte pharmazeutische zusammensetzung mit beschichteten pellets und direktes kompressionsgemisch und herstellungsverfahren dafür | |
IL169793A (en) | Compounds containing antacids and antioxidants and using them for the preparation of a medicinal product | |
IL164217A0 (en) | Pharmaceutical compositions containing water-soluble propofol and methods of administering same | |
MX2008001645A (es) | Composiciones de fexofendina en suspension farmaceutica oral. | |
AR030857A1 (es) | Derivados nitroso de difenolaminas, composiciones farmaceuticas que los contienen y su uso en la preparacion de productos medicinales | |
NO20051018L (no) | Farmasoytisk preparat inneholdende en benzimidazolforbindelse blandet med mikrokrystallinsk cellulose og en fremgangsmate for fremstilling derav | |
TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
ATE354362T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff | |
IS7595A (is) | Módafíníl lyfjasamsetningar | |
ATE302746T1 (de) | Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen | |
WO2006041843A3 (en) | Pharmaceutical dosage form comprising meloxicam | |
HUP0302099A3 (en) | Azythromycin in the form of a monohydrate, process for its preparation and pharmaceutical composition containing in the monohydrate form | |
HUP0300221A3 (en) | Use of oltipraz as an antifibrotic and anticirrhotic agent in the liver for producing pharmaceutical compositions and pharmaceutical compositions containing oltipraz and process for producing them | |
NO20054417L (no) | Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter | |
MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
RS51115B (sr) | Oralne formulacije kladribina | |
HUP0303673A3 (en) | Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient | |
IL169163A0 (en) | Optically active dihydropyridine derivative and pharmaceutical compositions containing the same |